$40M cancer deal gets Redx out of the red

00:57 EDT 1 Aug 2017 | BioPharmaDive

Loxo Oncology picks up a cancer drug from the beleaguered UK company that will help pay off debt. 

Original Article: $40M cancer deal gets Redx out of the red


More From BioPortfolio on "$40M cancer deal gets Redx out of the red"

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...